| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-10 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-09 |